Amana Healthcare

Amana Healthcare is a specialized medical provider of long-term acute care, post-acute rehabilitation, and transitional home healthcare services based in Abu Dhabi, United Arab Emirates. The organization operates multiple hospitals across Abu Dhabi, Al Ain, and Dubai to treat patients recovering from severe strokes, head injuries, or major surgeries. Generating revenue through private insurance reimbursements and government contracts, the company previously secured undisclosed mezzanine financing from Gulf Capital to fund its regional expansion. Following its 2019 acquisition by Mubadala Investment Company, the enterprise was integrated in 2023 into M42, a global health-technology entity formed through the merger of Mubadala Health and G42 Healthcare. Clinical operations are overseen by CEO Dr. Jason Gray, who brings over 25 years of experience from the United Kingdom's National Health Service. Amana Healthcare was founded in 2012 by Ali Hashemi and Mark McGourty.

High-Level Overview

Amana Healthcare is the Middle East’s leading provider of specialized long-term care, rehabilitation, and home healthcare services, pioneering integrated continuum-of-care in the GCC region.[1][2] Part of the M42 group (an Abu Dhabi-based tech-enabled health powerhouse) and previously under Mubadala Health, it serves patients with complex post-acute needs from the Middle East, Africa, and South Asia, offering inpatient rehabilitation, skilled nursing for conditions like long COVID, stroke, brain/spinal injuries, and joint replacements.[1][2][3] Operating hospitals in the UAE (Abu Dhabi and Al Ain) accredited by the U.S. Commission on Accreditation of Rehabilitation Facilities (CARF), it employs Western-trained physicians and emphasizes quality of life, functional outcomes, and inter-sectoral collaboration.[1][2][5] Amana serves a broad demographic requiring specialized post-acute care, addressing hospital overcrowding by providing transitional and home-based solutions, with expansion into Bahrain via partnership with Mumtalakat launching in 2025 to create jobs and enhance local healthcare.[3][4]

Origin Story

Amana Healthcare traces its roots to Mubadala Healthcare, established in 2006 as part of Mubadala's Alternative Investment & Infrastructure platform, which evolved into Mubadala Health in 2021 as an integrated network of facilities including Amana.[1] It emerged as a pioneer in post-acute care within the UAE, building on the vision to transform the regional healthcare landscape through commercially sustainable private sector development aligned with Abu Dhabi's goals.[1][2] Key milestones include CARF accreditation for its hospitals (first in 2022 for branches like Al Ain) and integration into the M42 network, combining G42's medical/data technologies with Mubadala Health's facilities.[2][4][5] Expansion to Bahrain in partnership with Mumtalakat (Bahrain's sovereign wealth fund) marks a pivotal moment, aligning with Vision 2030 for better healthcare accessibility and set to launch a specialized facility in 2025, supported by Tamkeen for job creation.[3][4]

Core Differentiators

• Pioneering Integrated Continuum-of-Care: First in the GCC to offer seamless post-acute services spanning inpatient rehabilitation, long-term care, transitional care, and home/telerehabilitation, reducing hospital pressure.[1][2][4]
• World-Class Accreditation and Expertise: CARF-accredited hospitals with Western-trained, highly experienced physicians; specialized programs like pediatric care and tailored rehab for complex cases (e.g., post-COVID, amputations).[2][5]
• Tech-Enabled via M42 Partnership: Leverages M42's data-centric technologies for personalized, precise care, combined with state-of-the-art facilities.[2][4]
• Broad Reach and Quality Focus: Serves diverse patients across regions with emphasis on functional outcomes, quality of life, ethics/compliance, and community stories of recovery.[1][2]
• Expansion and Economic Impact: New Bahrain facility (2025) with Mumtalakat creates skilled jobs, supported by Tamkeen, enhancing regional standards.[3][4]

Role in the Broader Tech Landscape

Amana rides the wave of tech-enabled healthcare transformation in the Middle East, where M42 integrates AI/data analytics with clinical services to deliver preventative, precise care amid rising demand for post-acute solutions post-pandemic.[2][4] Timing aligns with UAE and Bahrain's visions (e.g., Abu Dhabi’s private sector push, Bahrain Vision 2030) to build sustainable healthcare ecosystems, countering hospital overload from chronic/complex cases in aging populations and regions like South Asia/Africa.[1][3][4] Market forces favoring Amana include GCC investments in health infrastructure, sovereign fund partnerships (Mubadala, Mumtalakat), and global standards like CARF accreditation, positioning it to influence ecosystem-wide improvements in rehab/long-term care accessibility and outcomes.[1][5]

Quick Take & Future Outlook

Amana is poised for regional dominance in post-acute care, with the 2025 Bahrain launch accelerating growth through job creation (hundreds via Tamkeen) and M42's tech scaling to new markets.[3] Trends like AI-driven personalization, telemedicine expansion, and inter-GCC collaboration will shape its path, potentially extending to more M42 facilities and South Asian/African outposts. Its influence may evolve from UAE pioneer to pan-Middle East leader, redefining integrated care standards and easing public health burdens—building directly on its legacy as the region's post-acute trailblazer.[2][4]